Teresa Davoli | AIChE

Teresa Davoli

Assistant Professor
New York University

Dr. Davoli obtained her Ph.D. in 2013 from The Rockefeller University working with Dr. Titia de Lange on studying how telomere dysfunction promotes aneuploidy during tumorigenesis. During her postdoctoral training, she worked with Dr. Stephen Elledge using genomics approaches to understand the consequences of cancer aneuploidy for tumor formation and for therapy response in cancer patients. In May 2018, Dr. Davoli started her lab at the Institute for Systems Genetics at NYU School of Medicine in New York. Her lab uses functional genetics and computational approaches to study the causes and consequences of genomic instability in cancer. Dr. Davoli has received the Weintraub Graduate Student award in 2013 and she was a Helen Hay Whitney Postdoctoral Scholar. Dr. Davoli was a V Foundation Scholar and was also awarded the Melanoma Research Alliance Young Investigator Award, the Breast Cancer Alliance Young Investigator Award.

Her lab focuses on dissecting the causes and consequences of chromosome gains and losses in solid tumors, including colorectal cancer, breast cancer and melanoma. Dr. Davoli recently found that tumors with a high level of aneuploidy tend to be immune cold and to be refractory to immunotherapy. Her long-term goals are to decipher how aneuploidy can be utilized as a biomarker for therapy response and as a potential target for novel cancer treatments that take advantage of synthetic lethalities associated with the aneuploid state.